Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors (Q74611892)
Jump to navigation
Jump to search
scientific article published on 01 February 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors |
scientific article published on 01 February 1999 |
Statements
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors (English)
R L Drengler
J G Kuhn
L J Schaaf
G I Rodriguez
M A Villalona-Calero
L A Hammond
J A Stephenson
S Hodges
M A Kraynak
B A Staton
G L Elfring
P K Locker
L L Miller
D D Von Hoff
M L Rothenberg
1 February 1999